Author:
Petrovitch Charise T.,Drummond John C.
Reference25 articles.
1. Vischer UM, de Moerloose P. von Willebrand factor: from cell biology to the clinical management of von Willebrand’s disease. Crit Rev Oncol Hematol 1999;30:93–109.
2. Sadler JE, Matsushita T, Dong Z, Tuley EA, Westfield LA. Molecular mechanism and classification of von Willebrand disease. Thromb Haemost 1995; 74: 161–6.
3. Warrier AI, Lusher JM. DDAVP: a useful alternative to blood components in moderate hemophilia A and von Willebrand disease. J Pediatr 1983; 102: 228–33.
4. McLoughlin TM, Greilich PE. Blood: Hemostasis, transfusion, and alternatives in the perioperative period. In: Lake CL, Moore RA, eds. Blood: Hemostasis, Transfusion, and Alternatives in the Perioperative Period. New York: Raven Press, 1995: 25–70.
5. DeLoughery TG. Management of bleeding with uremia and liver disease. Cuff Opin Hematol 1999; 6: 329–33.